Sumagen the first to take whole-virus HIV vaccine into the clinic
This article was originally published in Scrip
Executive Summary
The South Korean firm Sumagen is taking its novel experimental HIV vaccine SAV001 into a Phase I trial in the US, marking the first time for a whole-killed virus vaccine for the disease to enter the clinic.